Related Experiment Video

Updated: Aug 13, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Reducing the risk of gynecologic cancer in the Lynch syndrome

Kenneth Offit, Noah D Kauff

    The New England Journal of Medicine
    |January 20, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: Aug 13, 2026

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
    09:48

    An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

    Published on: September 12, 2019

    Related Concept Videos

    Cancer Prevention02:59

    Cancer Prevention

    Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
    Some...

    Articles linked to this work by shared authors, journal, and citation graph.

    SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers.

    bioRxiv : the preprint server for biology·2026

    Cell-of-origin shapes tumor subtype in BRCA1 -associated triple-negative breast cancer.

    bioRxiv : the preprint server for biology·2026

    Universal Germline Genetic Testing after a Diagnosis of Cancer.

    Cancer discovery·2026

    Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment.

    Nature genetics·2026

    Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk.

    Nature communications·2026

    Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.

    Journal of the National Cancer Institute·2026

    Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.

    The New England journal of medicine·2026

    Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy.

    The New England journal of medicine·2026

    Sibeprenlimab in IgA Nephropathy - Final Phase 3 Trial Analysis.

    The New England journal of medicine·2026

    Atacicept in IgA Nephropathy - Phase 3 Trial Final Efficacy Analysis.

    The New England journal of medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us